Ulcerative Colitis (UC) is a form of inflammatory bowel disease (IBD) characterized by damage of large bowel mucosa and frequent extra-intestinal autoimmune comorbidities. The role played in IBD pathogenesis by molecular chaperones known to interact with components of the immune system involved in inflammation is unclear. We previously demonstrated that mucosal HSP60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis. In the present work we investigated three other heat sock protein/molecular chaperones:HSP10, HSP70; and HSP90. We found that the levels of these proteins are increased in UC patients at the time of diagnosis and decrease after therapy, supporting the notion that these proteins deserve attention in the study of the mechanism that promote the development and maintenance of IBD, and as biomarkers of this disease (c.g., to monitor response to treatment at the histological level).

Tomasello, G., Sciumè, C., Rappa, F., Rodolico, V., Zerilli, M., Martorana, A., et al. (2011). HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 55, 210-214.

HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY

TOMASELLO, Giovanni;SCIUME', Carmelo;RAPPA, Francesca;RODOLICO, VITO;ZERILLI, Monica;MARTORANA, Anna;CICERO, Giuseppe;DE LUCA, Rossella;ROMEO, Marcello;FARINA, Felicia;BONAVENTURA, Giuseppe;MODICA, Giuseppe;ZUMMO, Giovanni;CAPPELLO, Francesco
2011

Abstract

Ulcerative Colitis (UC) is a form of inflammatory bowel disease (IBD) characterized by damage of large bowel mucosa and frequent extra-intestinal autoimmune comorbidities. The role played in IBD pathogenesis by molecular chaperones known to interact with components of the immune system involved in inflammation is unclear. We previously demonstrated that mucosal HSP60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis. In the present work we investigated three other heat sock protein/molecular chaperones:HSP10, HSP70; and HSP90. We found that the levels of these proteins are increased in UC patients at the time of diagnosis and decrease after therapy, supporting the notion that these proteins deserve attention in the study of the mechanism that promote the development and maintenance of IBD, and as biomarkers of this disease (c.g., to monitor response to treatment at the histological level).
Tomasello, G., Sciumè, C., Rappa, F., Rodolico, V., Zerilli, M., Martorana, A., et al. (2011). HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 55, 210-214.
File in questo prodotto:
File Dimensione Formato  
HSP 10 HSP 70 AND HSP 90 IMMUNOHISTOCHEMICAL LEVELS. EUROPEAN JOURNAL OF HISTOCHEMISTRY 2011.pdf

non disponibili

Dimensione 589.81 kB
Formato Adobe PDF
589.81 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/62452
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 51
social impact